Inventor

KIM BYEONG MOON

KR8 patents

⚠️ This page may combine multiple inventors who share the name “KIM BYEONG MOON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SEOUL NAT UNIV R&DB FOUNDATION

4 patents

US11021455B2Jun 1, 2021

Brominated furanone derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient

SEOUL NAT UNIV R&DB FOUNDATION0 citations58

US10292993B2May 21, 2019

Method of inhibiting quorum sensing using D-galactose

SEOUL NAT UNIV R&DB FOUNDATION1 citations56

US12122812B2Oct 22, 2024

Method for preparing biomaterial having selectively functionalized tyrosine, biomaterial having selectively functionalized tyrosine, and pharmaceutical composition containing same as active ingredient

SEOUL NAT UNIV R&DB FOUNDATION0 citations45

US11261175B2Mar 1, 2022

Fluorene derivative or pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical composition comprising same as effective ingredient for preventing or treating HCV-related disease

SEOUL NAT UNIV R&DB FOUNDATION0 citations41

MERCK & CO INC

2 patents

US5811462ASep 22, 1998

HIV Protease inhibitors useful for the treatment of AIDS

MERCK & CO INC9 citations73

US5650412AJul 22, 1997

HIV protease inhibitors useful for the treatment of AIDS

MERCK & CO INC11 citations72

UNIV SEOUL NAT R & DB FOUND

1 patent

US9598362B2Mar 21, 2017

Benzidine derivative, method for preparing same, and pharmaceutical composition containing benzidine derivative for treating liver disease caused by hepatitis C virus

UNIV SEOUL NAT R & DB FOUND1 citations46

LEE SEUNG KI

1 patent

US9062088B2Jun 23, 2015

CDK-inhibiting pyrrolopyrimidine carboxamide derivative or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing the same as active ingredient for preventing or treating hepatocellular carcinoma

LEE SEUNG KI0 citations39